1 |
Cui YQ , Liu W . COVID-19 infection-associated multisystem inflammatory syndrome and cytokine storms in children. Tianjin Yi Yao, 2022, 50: 1340- 1344.
doi: 10.11958/20220587
|
|
崔亚琼, 刘薇. 新型冠状病毒感染相关儿童多系统炎症综合征与细胞因子风暴. 天津医药, 2022, 50: 1340- 1344.
doi: 10.11958/20220587
|
2 |
Guan HZ . Diagnosis and treatment of viral encephalitis. Zhonghua Shen Jing Ke Za Zhi, 2022, 55: 747- 754.
doi: 10.3760/cma.j.cn113694-20220308-00175
|
|
关鸿志. 病毒性脑炎的诊治. 中华神经科杂志, 2022, 55: 747- 754.
doi: 10.3760/cma.j.cn113694-20220308-00175
|
3 |
Mizuguchi M , Abe J , Mikkaichi K , Noma S , Yoshida K , Yamanaka T , Kamoshita S . Acute necrotising encephalopathy of childhood: a new syndrome presenting with multifocal, symmetric brain lesions. J Neurol Neurosurg Psychiatry, 1995, 58: 555- 561.
doi: 10.1136/jnnp.58.5.555
|
4 |
Tada H , Takanashi J , Barkovich AJ , Oba H , Maeda M , Tsukahara H , Suzuki M , Yamamoto T , Shimono T , Ichiyama T , Taoka T , Sohma O , Yoshikawa H , Kohno Y . Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology, 2004, 63: 1854- 1858.
doi: 10.1212/01.WNL.0000144274.12174.CB
|
5 |
Poyiadji N , Shahin G , Noujaim D , Stone M , Patel S , Griffith B . COVID-19-associated acute hemorrhagic necrotizing encephalopathy: imaging features. Radiology, 2020, 296: E119- E120.
doi: 10.1148/radiol.2020201187
|
6 |
Parauda SC , Gao V , Gewirtz AN , Parikh NS , Merkler AE , Lantos J , White H , Leifer D , Navi BB , Segal AZ . Posterior reversible encephalopathy syndrome in patients with COVID-19. J Neurol Sci, 2020, 416: 117019.
doi: 10.1016/j.jns.2020.117019
|
7 |
Maury A , Lyoubi A , Peiffer-Smadja N , de Broucker T , Meppiel E . Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: a narrative review for clinicians. Rev Neurol (Paris), 2021, 177 (1/2): 51- 64.
|
8 |
Dixon L , Varley J , Gontsarova A , Mallon D , Tona F , Muir D , Luqmani A , Jenkins IH , Nicholas R , Jones B , Everitt A . COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia. Neurol Neuroimmunol Neuroinflamm, 2020, 7: e789.
doi: 10.1212/NXI.0000000000000789
|
9 |
Jomaa N , El Halabi T , Melhem J , Dib G , Ghosn Y , Hourani M , Nasreddine W , Beydoun A . COVID-19-associated acute asymmetric hemorrhagic necrotizing encephalopathy: a case report. Neurohospitalist, 2022, 12: 371- 376.
doi: 10.1177/19418744211055360
|
10 |
Rettenmaier LA , Abdel-Wahed L , Abdelmotilib H , Conway KS , Narayanan N , Groth CL . COVID-19-associated necrotizing encephalopathy presenting without active respiratory symptoms: a case report with histopathology. J Neurovirol, 2022, 28: 172- 176.
doi: 10.1007/s13365-021-01042-3
|
11 |
Agha T , Moon JY , Iyer N . Acute necrotizing encephalopathy secondary to COVID-19. Proc (Bayl Univ Med Cent), 2022, 35: 512- 513.
|
12 |
Hayashi M , Sahashi Y , Baba Y , Okura H , Shimohata T . COVID-19-associated mild encephalitis/encephalopathy with a reversible splenial lesion. J Neurol Sci, 2020, 415: 116941.
doi: 10.1016/j.jns.2020.116941
|
13 |
Donaldson L , Margolin E . Posterior reversible encephalopathy syndrome in acute COVID-19 pneumonia. Can J Neurol Sci, 2022, 49: 791- 792.
doi: 10.1017/cjn.2021.221
|
14 |
Kobaidze K , Shin YM , Japaridze M , Karakis I , Wu X . Posterior reversible leukoencephalopathy syndrome in a patient after acute COVID-19 infection. Case Rep Neurol Med, 2021, ID5564802.
|
15 |
Hixon AM , Thaker AA , Pelak VS . Persistent visual dysfunction following posterior reversible encephalopathy syndrome due to COVID-19: case series and literature review. Eur J Neurol, 2021, 28: 3289- 3302.
doi: 10.1111/ene.14965
|
16 |
Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression[J]. Lancet, 2020, 395: 1033-1034.
|
17 |
Yang B , Tian L , Zang J , Shi LL , Yue H , Kong FB , Zheng JP . Acute necrotizing encephalopathy with onset of youth: a case report. Zhonghua Shen Jing Ke Za Zhi, 2019, 52: 123- 126.
doi: 10.3760/cma.j.issn.1006-7876.2019.02.008
|
|
杨波, 田莉, 臧静, 时丽丽, 岳红, 孔凡斌, 郑加平. 青年起病的急性坏死性脑病一例. 中华神经科杂志, 2019, 52: 123- 126.
doi: 10.3760/cma.j.issn.1006-7876.2019.02.008
|
18 |
Mao L , Jin H , Wang M , Hu Y , Chen S , He Q , Chang J , Hong C , Zhou Y , Wang D , Miao X , Li Y , Hu B . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol, 2020, 77: 683- 690.
doi: 10.1001/jamaneurol.2020.1127
|
19 |
Cao A , Rohaut B , Le Guennec L , Saheb S , Marois C , Altmayer V , Carpentier VT , Nemlaghi S , Soulie M , Morlon Q , Berthet-Delteil B , Bleibtreu A , Raux M , Weiss N , Demeret S , CoCo-Neurosciences Study Group . Severe COVID-19-related encephalitis can respond to immunotherapy. Brain, 2020, 143: e102.
doi: 10.1093/brain/awaa337
|
20 |
Kizilkilic EK , Unkun R , Uygunoglu U , Delil S , Ozkara C . Treatment of COVID-19-induced refractory status epilepticus by tocilizumab. Eur J Neurol, 2022, 29: 2861- 2863.
doi: 10.1111/ene.15440
|
21 |
Muccioli L , Pensato U , Cani I , Guerra L , Provini F , Bordin G , Riccioli LA , Lodi R , Tinuper P , Bisulli F . COVID-19-related encephalopathy presenting with aphasia resolving following tocilizumab treatment. J Neuroimmunol, 2020, 349: 577400.
doi: 10.1016/j.jneuroim.2020.577400
|
22 |
National Health Commission of the People's Republic of China . Diagnosis and treatment plan for COVID-19 (trial version 10). Zhonghua Lin Chuang Gan Ran Bing Za Zhi, 2023, 16: 1- 9.
doi: 10.3760/cma.j.issn.1674-2397.2023.01.001
|
|
中华人民共和国国家卫生健康委员会. 新型冠状病毒感染诊疗方案(试行第十版). 中华临床感染病杂志, 2023, 16: 1- 9.
doi: 10.3760/cma.j.issn.1674-2397.2023.01.001
|
23 |
Zhu J , Huang F . Fighting the 2019 novel coronavirus focus on cytokine storm. Zhonghua Feng Shi Bing Xue Za Zhi, 2020, 24: 425- 429.
doi: 10.3760/cma.j.cn141217-20200323-00117
|
|
朱剑, 黄烽. 抗击2019新型冠状病毒关注细胞因子风暴. 中华风湿病学杂志, 2020, 24: 425- 429.
doi: 10.3760/cma.j.cn141217-20200323-00117
|
24 |
Ziemele D , Ķauķe G , Skrējāne K , Jaunozoliņa L , Karelis G . A fatal case of COVID-19-associated acute necrotizing encephalopathy. Eur J Neurol, 2021, 28: 3870- 3872.
doi: 10.1111/ene.14966
|
25 |
Paterson RW , Brown RL , Benjamin L , Nortley R , Wiethoff S , Bharucha T , Jayaseelan DL , Kumar G , Raftopoulos RE , Zambreanu L , Vivekanandam V , Khoo A , Geraldes R , Chinthapalli K , Boyd E , Tuzlali H , Price G , Christofi G , Morrow J , McNamara P , McLoughlin B , Lim ST , Mehta PR , Levee V , Keddie S , Yong W , Trip SA , Foulkes AJM , Hotton G , Miller TD , Everitt AD , Carswell C , Davies NWS , Yoong M , Attwell D , Sreedharan J , Silber E , Schott JM , Chandratheva A , Perry RJ , Simister R , Checkley A , Longley N , Farmer SF , Carletti F , Houlihan C , Thom M , Lunn MP , Spillane J , Howard R , Vincent A , Werring DJ , Hoskote C , Jäger HR , Manji H , Zandi MS . The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain, 2020, 143: 3104- 3120.
doi: 10.1093/brain/awaa240
|
26 |
Zamani R , Pouremamali R , Rezaei N . Central neuroinflammation in COVID-19: a systematic review of 182 cases with encephalitis, acute disseminated encephalomyelitis, and necrotizing encephalopathies. Rev Neurosci, 2021, 33: 397- 412.
|